Target intelligence / Profile preview

3-oxoacyl-[acyl-carrier-protein] synthase 1

Molecular classification
Enzyme, Fatty acid synthase family, Condensing enzyme
01

Overview

3-oxoacyl-[acyl-carrier-protein] synthase 1 is an essential condensing enzyme in the type II fatty acid synthesis pathway. It catalyzes the addition of malonyl-ACP to an acyl-ACP, elongating the fatty acid chain by two carbons. It functions as a homodimer or tetramer and contains a catalytic cysteine residue. The enzyme is a validated antibacterial drug target; inhibitors of this enzyme block the biosynthesis of long-chain fatty acids, halting bacterial growth. Its homologs are also present in mitochondria, where they participate in fatty acid chain elongation mechanisms[6][7]. If further specificity is needed (e.g., specifying the organism or distinguishing among multiple isoforms such as KAS I, II, or III), consult the relevant UniProt or NCBI entry for sequence, structure, and organism context[6][7].

Other names
3-oxoacyl-[acyl-carrier-protein] synthase IKAS IFabBbeta-ketoacyl-ACP synthase Ibeta-ketoacyl-acyl carrier protein synthase 1
02

Mechanism of action

Inhibition of the condensation step in fatty acid synthesis, blocking cell membrane formation in bacteria[6]

03

Biological functions

Fatty acid biosynthesisElongation of acyl chainsCell membrane formation
04

Disease associations

Infection (crucial for bacterial viability, target for antibiotics)Other (implicated in metabolic functions in mitochondria)
05

Safety considerations

Selectivity: human fatty acid synthase can have homologous domains, requires selectivity for bacterial KAS I for antibacterial therapyPotential metabolic disruption in host if selectivity is poor
06

Interacting drugs

Thiolactomycin (KAS inhibitor)

2 more in the full profile.

Beyond the preview

Go deeper on 3-oxoacyl-[acyl-carrier-protein] synthase 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-oxoacyl-[acyl-carrier-protein] synthase 1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call